Synopsis:-In a major cross-border acquisition, IKS Health (NSE: IKS) has signed a definitive agreement to acquire NASDAQ-listed TruBridge, Inc. at $26.25 per share in an all-cash deal, targeting over 1,500 rural and community hospitals across the United States and unlocking a whitespace revenue opportunity exceeding $575 million within TruBridge’s existing client base.
Shares of a leading healthcare technology company surged sharply after it announced one of the most consequential acquisitions in its history: a full buyout of US-based TruBridge, Inc., a specialist in electronic health records and revenue cycle management for America’s rural hospital segment. The stock responded with force to the news, climbing over 9 percent in early trade on April 24.
With a market capitalization of Rs. 24,822 crore, the shares of Inventurus Knowledge Solutions Limited were trading at Rs. 1,564.90 per share, up 9 percent from their previous closing price of Rs. 1,435 apiece. It is trading at a P/E of 37.4.
Acquisition Update
IKS Health, through its US subsidiary Inventurus Knowledge Solutions, Inc., has entered into a binding agreement to acquire TruBridge, Inc. at $26.25 per share, an all-cash transaction that values TruBridge at a meaningful premium to its recent market price. The deal has been cleared by the boards of both companies and is expected to close in the third calendar quarter of 2026, subject to regulatory review under the Hart-Scott-Rodino Act and approvals from shareholders of both entities. Shareholders representing approximately 27 percent of TruBridge’s outstanding shares have already signed voting support agreements backing the transaction.
Financing comes from a term loan underwritten by Citibank, JPMorgan Chase, and Deutsche Bank. Post-transaction, IKS has indicated a leverage ratio of approximately 3 times within its stated risk tolerance, pointing to its successful deleveraging after the earlier Aquity acquisition as a reference track record.
Why TruBridge, and Why Now
The deal fills a gap IKS could not organically address. While IKS built its base in ambulatory care and physician groups, TruBridge works with small-to-mid-sized acute care hospitals and rural facilities, a segment serving nearly one in five Americans who face barriers to accessing care. The two client bases do not overlap, meaning the acquisition adds scale without cannibalizing existing revenue.
TruBridge brings three specific assets into the fold. Its proprietary EHR platform is the system of record for over 1,500 clients, giving IKS a direct distribution channel to cross-sell its Care Enablement Platform and AI-driven RCM tools. TruCode, its medical encoder with over 6 million built-in rules, commands a $650 million addressable market with 95 percent coding accuracy. Viewgol, its analytics platform, enables predictive denial management and real-time clinician dashboard capabilities. IKS can layer across its existing ambulatory client base as well.
The revenue arithmetic is straightforward. IKS has identified over $440 million in immediate RCM whitespace among TruBridge clients currently using only EHR software, with the broader bundled platform opportunity scaling to $575 million. The outsourced rural RCM market itself is growing at 12 to 13 percent annually, with 70 to 75 percent of that market still handled in-house, leaving substantial room for managed service penetration.
Business Overview
Inventurus Knowledge Solutions Limited is a technology-enabled healthcare solutions company headquartered in Thane, Maharashtra. Founded in 2006, it offers a care enablement platform to physician enterprises and healthcare systems primarily in the United States.
In Q3 FY26, the company reported revenue of Rs. 815 crore, up 24 percent year-on-year, with net profit rising 41 percent to Rs. 183 crore. EBITDA margin expanded to 34.6 percent from 30.5 percent in the same quarter a year earlier.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
The post IT Stock Jumps 9% After Co. to Acquire NASDAQ-Listed TruBridge Worth $575 Mil appeared first on Trade Brains.